KOAN Stock Overview
Engages in the discovery, development, and marketing of products designed to mankind.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Resonate Blends, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0056 |
| 52 Week High | US$0.075 |
| 52 Week Low | US$0.0051 |
| Beta | 2.87 |
| 11 Month Change | -20.00% |
| 3 Month Change | -72.89% |
| 1 Year Change | -76.80% |
| 33 Year Change | -98.07% |
| 5 Year Change | -96.89% |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| KOAN | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -9.7% | -3.7% | -1.6% |
| 1Y | -76.8% | 17.2% | 30.8% |
Return vs Industry: KOAN underperformed the US Pharmaceuticals industry which returned 17.2% over the past year.
Return vs Market: KOAN underperformed the US Market which returned 30.8% over the past year.
Price Volatility
| KOAN volatility | |
|---|---|
| KOAN Average Weekly Movement | 26.9% |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: KOAN's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: KOAN's weekly volatility has decreased from 50% to 27% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 6 | n/a | www.resonateblends.com |
Resonate Blends, Inc. engages in the discovery, development, and marketing of products designed to mankind. The company focuses on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual’s ability to mobilize their own adult stem cells from their bone marrow. It also has a license to market a dual acting all natural diet aid designed to help control hunger through normal body signals to the brain and stomach.
Resonate Blends, Inc. Fundamentals Summary
| KOAN fundamental statistics | |
|---|---|
| Market cap | US$642.57k |
| Earnings (TTM) | -US$1.88m |
| Revenue (TTM) | US$751.28k |
0.7x
P/S Ratio-0.3x
P/E RatioIs KOAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KOAN income statement (TTM) | |
|---|---|
| Revenue | US$751.28k |
| Cost of Revenue | US$398.81k |
| Gross Profit | US$352.47k |
| Other Expenses | US$2.24m |
| Earnings | -US$1.88m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 46.92% |
| Net Profit Margin | -250.64% |
| Debt/Equity Ratio | -133.3% |
How did KOAN perform over the long term?
See historical performance and comparison